GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BTG PLC (OTCPK:BTGGF) » Definitions » Price-to-Owner-Earnings

BTG (BTGGF) Price-to-Owner-Earnings : (As of Apr. 28, 2024)


View and export this data going back to . Start your Free Trial

What is BTG Price-to-Owner-Earnings?

As of today (2024-04-28), BTG's share price is $51.50. BTG does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for BTG's Price-to-Owner-Earnings or its related term are showing as below:


BTGGF's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 31.62
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-04-28), BTG's share price is $51.50. BTG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2019 was $0.29. Therefore, BTG's PE Ratio for today is 180.70.

As of today (2024-04-28), BTG's share price is $51.50. BTG's EPS without NRI for the trailing twelve months (TTM) ended in was $0.29. Therefore, BTG's PE Ratio without NRI for today is 180.70.


BTG Price-to-Owner-Earnings Historical Data

The historical data trend for BTG's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BTG Price-to-Owner-Earnings Chart

BTG Annual Data
Trend Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.39 27.94 39.30 18.25 38.99

BTG Semi-Annual Data
Sep09 Mar10 Sep10 Mar11 Sep11 Mar12 Sep12 Mar13 Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.30 - 18.25 - 38.99

Competitive Comparison of BTG's Price-to-Owner-Earnings

For the Biotechnology subindustry, BTG's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BTG's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BTG's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where BTG's Price-to-Owner-Earnings falls into.



BTG Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

BTG's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=51.50/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BTG  (OTCPK:BTGGF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


BTG Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of BTG's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


BTG (BTGGF) Business Description

Traded in Other Exchanges
N/A
Address
5 Fleet Place, London, GBR, EC4M 7RD
BTG is a biotechnology company that develops products in specialty areas of medicine. The company's three operating segments are interventional medicine, specialty pharmaceuticals, and licensing. Its interventional medicine focuses on oncology, vascular treatments, and pulmonology. BTG's revenue is roughly split between these three segments, while its oncology operations lead the interventional segment. The company has been known to utilize acquisitions for investing in leading therapies and capabilities.